Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECYCLE: eHealth Support in HR+/HER2- Metastatic Breast Cancer
NCT03220178Phase 4Terminated
- Sponsor
- Palleos Healthcare
- Start
- Jul 2017
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in breast cancer (2 arms), sponsored by Palleos Healthcare. Primary endpoint: Time to Deterioration of Quality of Life up to 4 years. Started Jul 2017; status: terminated.
02
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03220178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03220178.